49 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18754913 | HEALTH INFORMATION PLATFORM | KHATTAR, RAJESH | 3684 | Final Rejection | Jun 26, 2024 |
| 18722420 | WEARABLE COMPANION FOR DETECTING THE CYTOKINE RELEASE SYNDROME | ABDULLAH, AAISHA | 3681 | Non-Final OA | Jun 20, 2024 |
| 18535116 | IMMUNOGENIC COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIOIDES (CLOSTRIDIUM) DIFFICILE | HAUK TEODORO, PRICILA NMN | 1645 | Non-Final OA | Dec 11, 2023 |
| 18528539 | ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES | MCCOLLUM, ANDREA K | 1674 | Final Rejection | Dec 04, 2023 |
| 18562387 | RECOMBINANT EXPRESSION OF KLEBSIELLA PNEUMONIAE O-ANTIGENS IN ESCHERICHIA COLI | GANGLE, BRIAN J | 1645 | Non-Final OA | Nov 20, 2023 |
| 18557987 | VACCINATION AGAINST BACTERIAL AND BETACORONAVIRUS INFECTIONS | FOLEY, SHANON A | 1671 | Non-Final OA | Oct 30, 2023 |
| 18488191 | COMPOUND FOR THE TREATMENT OF CANCER | KLINKEL, KORTNEY L | 1627 | Non-Final OA | Oct 17, 2023 |
| 18555058 | COMBINATION THERAPY COMPRISING A PKC INHIBITOR AND A MEK INHIBITOR | O DELL, DAVID K | 1621 | Non-Final OA | Oct 12, 2023 |
| 18552453 | Ether-Linked Antiviral Compounds | ANDERSON, REBECCA L | 1626 | Non-Final OA | Sep 26, 2023 |
| 18551038 | PHARMACEUTICAL COMPOSITIONS CONTAINING ADENO-ASSOCIATED VIRAL VECTOR | SMITH, ADAM MICHAEL | 1638 | Non-Final OA | Sep 18, 2023 |
| 18549158 | Treatment of Breast Cancer with Amcenestrant and Palbociclib | LEESER, ERICH A | 1622 | Non-Final OA | Sep 05, 2023 |
| 18459381 | CELL CULTURE PROCESS | NGUYEN, NGHI V | 1653 | Non-Final OA | Aug 31, 2023 |
| 18275634 | Methods of Protecting RNA | MCKILLOP, JOHN CHARLES | 1637 | Non-Final OA | Aug 03, 2023 |
| 18359250 | Dosing Regime For Treatment of Chronic Hand Eczema | BREDEFELD, RACHAEL EVA | 3786 | Non-Final OA | Jul 26, 2023 |
| 18350986 | CELLS AND METHOD OF CELL CULTURE | HUMPHRIES, NICHOLAS ADAM | 1631 | Non-Final OA | Jul 12, 2023 |
| 18347698 | SELF-AMPLIFYING RNA ENCODING AN INFLUENZA VIRUS ANTIGEN | CHEN, STACY BROWN | 1672 | Non-Final OA | Jul 06, 2023 |
| 18255869 | METHODS AND COMPOSITIONS FOR INHIBITING EXCESS NUCLEIC ACID PRECIPITATION | TSAY, MARSHA M | 1656 | Non-Final OA | Jun 04, 2023 |
| 18255868 | METHODS FOR PURIFICATION OF AAV VECTORS BY AFFINITY CHROMATOGRAPHY | TINSLEY, BRENDAN THOMAS | 1634 | Non-Final OA | Jun 04, 2023 |
| 18322395 | PURIFICATION OF ANTIBODY DRUG CONJUGATES USING A SODIUM PHOSPHATE GRADIENT | GAMETT, DANIEL C | 1647 | Non-Final OA | May 23, 2023 |
| 18036760 | SYSTEM AND METHOD FOR NEEDLE HIDING IN INJECTORS | LANGE, ERIC A | 3783 | Non-Final OA | May 12, 2023 |
| 18036141 | TALAZOPARIB SOFT GELATIN CAPSULE DOSAGE FORM | MERCIER, MELISSA S | 1615 | Final Rejection | May 09, 2023 |
| 18252124 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | OGUNBIYI, OLUWATOSIN A | 1645 | Non-Final OA | May 08, 2023 |
| 18034239 | IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES | MORGAN, BAILEY MICHELLE | 1645 | Non-Final OA | Apr 27, 2023 |
| 18250570 | CRYSTAL-FREE HIGH-CONCENTRATION TESTOSTERONE CYPIONATE FORMULATIONS | MITCHELL, EDWIN COLEMAN | 1619 | Final Rejection | Apr 26, 2023 |
| 18250252 | Methods for Purification of AAV Vectors by Anion Exchange Chromatography | ALAM, DANYAL HASSAN | 1672 | Non-Final OA | Apr 24, 2023 |
| 18249411 | Methods for purifying bacterial polysaccharides | PATEL, PRANAV N | 1777 | Non-Final OA | Apr 18, 2023 |
| 18301475 | Benzimidazole Derivative Compounds and Uses Thereof | HASTINGS, ALISON AZAR | 1627 | Non-Final OA | Apr 17, 2023 |
| 18247565 | Cell culture process for producing RSV F protein | CHESTNUT, BARRY A | 1672 | Non-Final OA | Mar 31, 2023 |
| 18025879 | METHODS, THERAPIES AND USES FOR TREATING CANCER | HOLTZMAN, KATHERINE ANN | 1646 | Non-Final OA | Mar 10, 2023 |
| 18024245 | STREAMLINED ASSAY PREPARATION | YOUNG, NATASHA E | 1774 | Non-Final OA | Mar 01, 2023 |
| 18175796 | MULTISPECIFIC ANTIBODIES AND USES THEREOF | HECK, BRYAN WILLIAM | 1643 | Non-Final OA | Feb 28, 2023 |
| 18041447 | Methods of Protecting RNA | BATES, KEENAN ALEXANDER | 1631 | Non-Final OA | Feb 13, 2023 |
| 18006800 | IMPROVEMENTS TO WASH SOLUTIONS FOR ANION EXCHANGE CHROMATOGRAPHY IN A METHOD OF PURIFICATION OF RECOMBINANTLY-PRODUCED RSV PROTEINS | IANNUZO, NATALIE NMN | 1653 | Non-Final OA | Jan 25, 2023 |
| 18004965 | Polymorphs of (1S,2S,3S,5R)-3-((6-(Difluoromethyl)-5-Fluoro-1,2,3,4-Tetrahydroisoquinolin-8-YL)OXY)-5-(4-Methyl-7H-Pyrrolo[2,3-D]Pyrimidin-7-YL)Cyclopentane-1,2-DIOL Mono-Hydrochloride | HIRAKIS, SOPHIA P | 1623 | Non-Final OA | Jan 10, 2023 |
| 18004109 | Preparation Of A Pyrimidinyl-3,8-Diazabicyclo[3.2.1]Octanylmethanone Derivative And Salt Thereof | MOORE, SUSANNA | 1624 | Non-Final OA | Jan 03, 2023 |
| 18146014 | COMBINATION OF AN ANTI-PD-L1 ANTIBODY AND A DNA-PK INHIBITOR FOR THE TREATMENT OF CANCER | JOHANSEN, PETER N. | 1644 | Final Rejection | Dec 23, 2022 |
| 17924975 | METHODS, THERAPIES AND USES FOR TREATING CANCER | DENT, ALANA HARRIS | 1643 | Final Rejection | Nov 11, 2022 |
| 17997312 | MODIFIED NUCLEIC ACIDS ENCODING ASPARTOACYLASE (ASPA) AND VECTOR FOR GENE THERAPY | ALLEN, SARAH ELIZABETH | 1637 | Non-Final OA | Oct 27, 2022 |
| 17997091 | PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES | WILLIS, DOUGLAS M | 1624 | Non-Final OA | Oct 25, 2022 |
| 18045967 | RNA MOLECULES | CHEN, STACY BROWN | 1672 | Non-Final OA | Oct 12, 2022 |
| 17837891 | COMPOSITIONS AND METHODS FOR TREATMENT OF ABNORMAL CELL GROWTH | PEEBLES, KATHERINE | 1617 | Non-Final OA | Jun 10, 2022 |
| 17733566 | IMMUNOGENIC COMPOSITION AGAINST INFLUENZA | LI, BAO Q | 1671 | Final Rejection | Apr 29, 2022 |
| 17607341 | REAL-TIME TRACKING AND MANAGEMENT OF STANDARD WORKFLOWS | KONERU, SUJAY | 3624 | Final Rejection | Oct 28, 2021 |
| 17431462 | Methods for purifying bacterial polysaccharides | CREWS, JARET JAMES | 1691 | Non-Final OA | Aug 17, 2021 |
| 17312185 | Immunogenic Multiple Hetero-Antigen Polysaccharide-Protein Conjugates and uses thereof | FOLEY, SHANON A | 1671 | Non-Final OA | Jun 09, 2021 |
| 17283801 | Dosage Regimen for TFPI Antagonists | ALSOMAIRY, SARAH ABDOALATIF | 1646 | Final Rejection | Apr 08, 2021 |
| 17125555 | STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF | LYONS, MARY M | 1645 | Final Rejection | Dec 17, 2020 |
| 16978354 | ANTI-PD-1 ANTIBODY COMPOSITIONS | ALSOMAIRY, SARAH ABDOALATIF | 1646 | Final Rejection | Sep 04, 2020 |
| 15761777 | Method Of Preparing A Therapeutic Protein Formulation And Antibody Formulation Produced By Such A Method | KIM, YUNSOO | 1641 | Final Rejection | Mar 20, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial